DIET IN A PILL

THE FDA IS SET TO APPROVE ANOTHER ANTIOBESITY DRUG

As if it weren't already hard enough to get Americans to eat less and exercise more, an advisory panel to the Food and Drug Administration last week gave the green light to yet another weight-loss shortcut, recommending approval of a new drug, called orlistat, that prevents the body from absorbing as much as 30% of the fat it takes in.

The new diet-in-a-pill, to be marketed as Xenical, works by disabling pancreatic enzymes that help the intestines absorb the fat in foods. The drug produces "a kind of intestinal aversion" to fat, explains Dr. Jules Hirsch of Rockefeller University, an FDA...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!